nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—P2RY12—systemic lupus erythematosus	0.737	1	CbGaD
Treprostinil—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0255	0.402	CbGbCtD
Treprostinil—CYP2C9—Dapsone—systemic lupus erythematosus	0.0182	0.286	CbGbCtD
Treprostinil—CYP2C9—cardial valve—systemic lupus erythematosus	0.0124	0.247	CbGeAlD
Treprostinil—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0119	0.188	CbGbCtD
Treprostinil—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00786	0.124	CbGbCtD
Treprostinil—P2RY12—blood plasma—systemic lupus erythematosus	0.00612	0.122	CbGeAlD
Treprostinil—PTGIR—endothelium—systemic lupus erythematosus	0.0044	0.0874	CbGeAlD
Treprostinil—Epoprostenol—P2RY12—systemic lupus erythematosus	0.00407	1	CrCbGaD
Treprostinil—PTGIR—blood plasma—systemic lupus erythematosus	0.00391	0.0776	CbGeAlD
Treprostinil—CYP2C9—urine—systemic lupus erythematosus	0.00267	0.0532	CbGeAlD
Treprostinil—PTGIR—connective tissue—systemic lupus erythematosus	0.00208	0.0413	CbGeAlD
Treprostinil—PPARD—lymphoid tissue—systemic lupus erythematosus	0.00198	0.0394	CbGeAlD
Treprostinil—PPARD—tendon—systemic lupus erythematosus	0.00186	0.037	CbGeAlD
Treprostinil—P2RY12—nervous system—systemic lupus erythematosus	0.00182	0.0362	CbGeAlD
Treprostinil—PTGIR—kidney—systemic lupus erythematosus	0.00177	0.0352	CbGeAlD
Treprostinil—P2RY12—central nervous system—systemic lupus erythematosus	0.00175	0.0349	CbGeAlD
Treprostinil—PPARD—lung—systemic lupus erythematosus	0.00163	0.0325	CbGeAlD
Treprostinil—PPARD—nervous system—systemic lupus erythematosus	0.00151	0.0301	CbGeAlD
Treprostinil—PPARD—central nervous system—systemic lupus erythematosus	0.00146	0.029	CbGeAlD
Treprostinil—CYP2C9—blood plasma—systemic lupus erythematosus	0.0014	0.0277	CbGeAlD
Treprostinil—PTGIR—lung—systemic lupus erythematosus	0.00125	0.0249	CbGeAlD
Treprostinil—PTGIR—nervous system—systemic lupus erythematosus	0.00116	0.0231	CbGeAlD
Treprostinil—PTGIR—central nervous system—systemic lupus erythematosus	0.00112	0.0222	CbGeAlD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000576	0.0135	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000556	0.013	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000519	0.0121	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000508	0.0119	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—NOS3—systemic lupus erythematosus	0.000446	0.0104	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.00044	0.0103	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000402	0.00939	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000392	0.00916	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000366	0.00855	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—GADD45A—systemic lupus erythematosus	0.000364	0.00852	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000351	0.00821	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	0.000347	0.00813	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	0.00031	0.00724	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—RXRA—systemic lupus erythematosus	0.000301	0.00704	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—NOS3—systemic lupus erythematosus	0.000292	0.00683	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	0.000281	0.00658	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000274	0.00641	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000274	0.0064	CbGpPWpGaD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—RXRA—systemic lupus erythematosus	0.000273	0.00638	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—NR3C1—systemic lupus erythematosus	0.000245	0.00574	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—FAS—systemic lupus erythematosus	0.000238	0.00556	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000234	0.00548	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	0.000232	0.00542	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—NOS3—systemic lupus erythematosus	0.000224	0.00524	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.000216	0.00504	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	0.000211	0.00494	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ITGAX—systemic lupus erythematosus	0.000201	0.0047	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—F3—systemic lupus erythematosus	0.000198	0.00463	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—PPARG—systemic lupus erythematosus	0.00019	0.00444	CbGpPWpGaD
Treprostinil—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000186	0.00434	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ITGAX—systemic lupus erythematosus	0.000185	0.00433	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—F3—systemic lupus erythematosus	0.000182	0.00426	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000182	0.00425	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—CLU—systemic lupus erythematosus	0.000179	0.00419	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000179	0.00418	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—CCL2—systemic lupus erythematosus	0.000175	0.00409	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000171	0.00401	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CLU—systemic lupus erythematosus	0.000165	0.00386	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MTA2—systemic lupus erythematosus	0.000164	0.00384	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	0.000164	0.00383	CbGpPWpGaD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.00016	0.00375	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—P2RY12—systemic lupus erythematosus	0.00016	0.00373	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SELE—systemic lupus erythematosus	0.00016	0.00373	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—CSK—systemic lupus erythematosus	0.00016	0.00373	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000158	0.00369	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	0.000153	0.00358	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—EP300—systemic lupus erythematosus	0.000151	0.00353	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ITGAM—systemic lupus erythematosus	0.00015	0.00351	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.000148	0.00346	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CSK—systemic lupus erythematosus	0.000147	0.00344	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SELE—systemic lupus erythematosus	0.000147	0.00344	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	0.000146	0.00343	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—LYN—systemic lupus erythematosus	0.000145	0.00339	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.000144	0.00338	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SH2B3—systemic lupus erythematosus	0.000142	0.00333	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ITGAM—systemic lupus erythematosus	0.000138	0.00323	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000137	0.00321	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—LYN—systemic lupus erythematosus	0.000133	0.00312	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	0.000133	0.00311	CbGpPWpGaD
Treprostinil—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000132	0.00129	CcSEcCtD
Treprostinil—Angioedema—Betamethasone—systemic lupus erythematosus	0.000132	0.00129	CcSEcCtD
Treprostinil—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00128	CcSEcCtD
Treprostinil—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000132	0.00128	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—SH2B3—systemic lupus erythematosus	0.000131	0.00306	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—CDKN1A—systemic lupus erythematosus	0.000131	0.00306	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000131	0.00305	CbGpPWpGaD
Treprostinil—Malaise—Betamethasone—systemic lupus erythematosus	0.000131	0.00127	CcSEcCtD
Treprostinil—Malaise—Dexamethasone—systemic lupus erythematosus	0.000131	0.00127	CcSEcCtD
Treprostinil—Oedema—Triamcinolone—systemic lupus erythematosus	0.00013	0.00127	CcSEcCtD
Treprostinil—Syncope—Betamethasone—systemic lupus erythematosus	0.00013	0.00126	CcSEcCtD
Treprostinil—Syncope—Dexamethasone—systemic lupus erythematosus	0.00013	0.00126	CcSEcCtD
Treprostinil—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.00126	CcSEcCtD
Treprostinil—Infection—Triamcinolone—systemic lupus erythematosus	0.000129	0.00126	CcSEcCtD
Treprostinil—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000129	0.00126	CcSEcCtD
Treprostinil—Infection—Methylprednisolone—systemic lupus erythematosus	0.000129	0.00125	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—systemic lupus erythematosus	0.000129	0.00125	CcSEcCtD
Treprostinil—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000128	0.00125	CcSEcCtD
Treprostinil—Vomiting—Leflunomide—systemic lupus erythematosus	0.000128	0.00125	CcSEcCtD
Treprostinil—Shock—Triamcinolone—systemic lupus erythematosus	0.000128	0.00125	CcSEcCtD
Treprostinil—Insomnia—Prednisolone—systemic lupus erythematosus	0.000128	0.00124	CcSEcCtD
Treprostinil—Shock—Methylprednisolone—systemic lupus erythematosus	0.000128	0.00124	CcSEcCtD
Treprostinil—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Rash—Leflunomide—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000127	0.00124	CcSEcCtD
Treprostinil—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000127	0.00123	CcSEcCtD
Treprostinil—Nausea—Azathioprine—systemic lupus erythematosus	0.000127	0.00123	CcSEcCtD
Treprostinil—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00123	CcSEcCtD
Treprostinil—Headache—Leflunomide—systemic lupus erythematosus	0.000126	0.00123	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000126	0.00295	CbGpPWpGaD
Treprostinil—Erythema—Prednisone—systemic lupus erythematosus	0.000126	0.00123	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000126	0.00122	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000125	0.00293	CbGpPWpGaD
Treprostinil—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.00122	CcSEcCtD
Treprostinil—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000125	0.00122	CcSEcCtD
Treprostinil—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000124	0.00121	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00121	CcSEcCtD
Treprostinil—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000123	0.0012	CcSEcCtD
Treprostinil—Myalgia—Betamethasone—systemic lupus erythematosus	0.000123	0.0012	CcSEcCtD
Treprostinil—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000123	0.0012	CcSEcCtD
Treprostinil—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000123	0.0012	CcSEcCtD
Treprostinil—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000123	0.00119	CcSEcCtD
Treprostinil—Anxiety—Betamethasone—systemic lupus erythematosus	0.000123	0.00119	CcSEcCtD
Treprostinil—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000122	0.00118	CcSEcCtD
Treprostinil—Discomfort—Betamethasone—systemic lupus erythematosus	0.000122	0.00118	CcSEcCtD
Treprostinil—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00118	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000122	0.00118	CcSEcCtD
Treprostinil—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00118	CcSEcCtD
Treprostinil—Pain—Prednisolone—systemic lupus erythematosus	0.000121	0.00118	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000121	0.00118	CcSEcCtD
Treprostinil—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.00012	0.00117	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00012	0.00281	CbGpPWpGaD
Treprostinil—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.00012	0.00117	CcSEcCtD
Treprostinil—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.00117	CcSEcCtD
Treprostinil—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.00117	CcSEcCtD
Treprostinil—Nausea—Leflunomide—systemic lupus erythematosus	0.00012	0.00116	CcSEcCtD
Treprostinil—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000119	0.00116	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000119	0.00115	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000118	0.00115	CcSEcCtD
Treprostinil—Pain—Hydrocortisone—systemic lupus erythematosus	0.000118	0.00115	CcSEcCtD
Treprostinil—Oedema—Betamethasone—systemic lupus erythematosus	0.000118	0.00115	CcSEcCtD
Treprostinil—Oedema—Dexamethasone—systemic lupus erythematosus	0.000118	0.00115	CcSEcCtD
Treprostinil—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000118	0.00114	CcSEcCtD
Treprostinil—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000117	0.00114	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000117	0.00275	CbGpPWpGaD
Treprostinil—Infection—Betamethasone—systemic lupus erythematosus	0.000117	0.00114	CcSEcCtD
Treprostinil—Infection—Dexamethasone—systemic lupus erythematosus	0.000117	0.00114	CcSEcCtD
Treprostinil—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000117	0.00114	CcSEcCtD
Treprostinil—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000117	0.00114	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000117	0.00113	CcSEcCtD
Treprostinil—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000117	0.00113	CcSEcCtD
Treprostinil—Anaemia—Prednisone—systemic lupus erythematosus	0.000117	0.00113	CcSEcCtD
Treprostinil—Shock—Dexamethasone—systemic lupus erythematosus	0.000116	0.00113	CcSEcCtD
Treprostinil—Shock—Betamethasone—systemic lupus erythematosus	0.000116	0.00113	CcSEcCtD
Treprostinil—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000116	0.00113	CcSEcCtD
Treprostinil—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000116	0.00112	CcSEcCtD
Treprostinil—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000116	0.00112	CcSEcCtD
Treprostinil—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000115	0.00112	CcSEcCtD
Treprostinil—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000115	0.00112	CcSEcCtD
Treprostinil—Angioedema—Prednisone—systemic lupus erythematosus	0.000115	0.00112	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000115	0.00269	CbGpPWpGaD
Treprostinil—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000115	0.00111	CcSEcCtD
Treprostinil—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00111	CcSEcCtD
Treprostinil—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000114	0.00111	CcSEcCtD
Treprostinil—Malaise—Prednisone—systemic lupus erythematosus	0.000114	0.00111	CcSEcCtD
Treprostinil—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000113	0.0011	CcSEcCtD
Treprostinil—Syncope—Prednisone—systemic lupus erythematosus	0.000113	0.0011	CcSEcCtD
Treprostinil—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000113	0.00109	CcSEcCtD
Treprostinil—Anorexia—Betamethasone—systemic lupus erythematosus	0.000113	0.00109	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000112	0.00263	CbGpPWpGaD
Treprostinil—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000112	0.00109	CcSEcCtD
Treprostinil—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000112	0.00109	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IFNA1—systemic lupus erythematosus	0.000112	0.00261	CbGpPWpGaD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000112	0.00261	CbGpPWpGaD
Treprostinil—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000112	0.00109	CcSEcCtD
Treprostinil—Pain—Triamcinolone—systemic lupus erythematosus	0.000111	0.00108	CcSEcCtD
Treprostinil—PPARD—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000111	0.0026	CbGpPWpGaD
Treprostinil—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000111	0.00108	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000111	0.00259	CbGpPWpGaD
Treprostinil—Hypotension—Dexamethasone—systemic lupus erythematosus	0.00011	0.00107	CcSEcCtD
Treprostinil—Hypotension—Betamethasone—systemic lupus erythematosus	0.00011	0.00107	CcSEcCtD
Treprostinil—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00011	0.00107	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.00011	0.00257	CbGpPWpGaD
Treprostinil—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000109	0.00106	CcSEcCtD
Treprostinil—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000109	0.00106	CcSEcCtD
Treprostinil—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000109	0.00106	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000109	0.00255	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000108	0.00253	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TGFB1—systemic lupus erythematosus	0.000108	0.00253	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000108	0.00105	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000108	0.00105	CcSEcCtD
Treprostinil—PPARD—Gene Expression—SNRPB—systemic lupus erythematosus	0.000107	0.00251	CbGpPWpGaD
Treprostinil—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Myalgia—Prednisone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Anxiety—Prednisone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Insomnia—Betamethasone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000107	0.00104	CcSEcCtD
Treprostinil—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000106	0.00103	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000106	0.00103	CcSEcCtD
Treprostinil—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000106	0.00103	CcSEcCtD
Treprostinil—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000106	0.00103	CcSEcCtD
Treprostinil—Discomfort—Prednisone—systemic lupus erythematosus	0.000106	0.00103	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000106	0.00247	CbGpPWpGaD
Treprostinil—Erythema—Methotrexate—systemic lupus erythematosus	0.000105	0.00102	CcSEcCtD
Treprostinil—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000104	0.00101	CcSEcCtD
Treprostinil—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000104	0.00101	CcSEcCtD
Treprostinil—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00101	CcSEcCtD
Treprostinil—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000103	0.001	CcSEcCtD
Treprostinil—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000103	0.001	CcSEcCtD
Treprostinil—Oedema—Prednisone—systemic lupus erythematosus	0.000103	0.001	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IFNA1—systemic lupus erythematosus	0.000103	0.00241	CbGpPWpGaD
Treprostinil—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000998	CcSEcCtD
Treprostinil—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000103	0.000998	CcSEcCtD
Treprostinil—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000103	0.000998	CcSEcCtD
Treprostinil—Infection—Prednisone—systemic lupus erythematosus	0.000102	0.000994	CcSEcCtD
Treprostinil—Back pain—Methotrexate—systemic lupus erythematosus	0.000102	0.000991	CcSEcCtD
Treprostinil—Fatigue—Betamethasone—systemic lupus erythematosus	0.000102	0.00099	CcSEcCtD
Treprostinil—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000102	0.00099	CcSEcCtD
Treprostinil—Shock—Prednisone—systemic lupus erythematosus	0.000101	0.000984	CcSEcCtD
Treprostinil—Pain—Betamethasone—systemic lupus erythematosus	0.000101	0.000982	CcSEcCtD
Treprostinil—Pain—Dexamethasone—systemic lupus erythematosus	0.000101	0.000982	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TNF—systemic lupus erythematosus	0.000101	0.00236	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000101	0.00236	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000101	0.00236	CbGpPWpGaD
Treprostinil—Tachycardia—Prednisone—systemic lupus erythematosus	0.0001	0.000976	CcSEcCtD
Treprostinil—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.0001	0.000976	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—RASGRP1—systemic lupus erythematosus	0.0001	0.00234	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—VDR—systemic lupus erythematosus	9.95e-05	0.00233	CbGpPWpGaD
Treprostinil—Asthenia—Hydrocortisone—systemic lupus erythematosus	9.92e-05	0.000965	CcSEcCtD
Treprostinil—Vomiting—Cyclosporine—systemic lupus erythematosus	9.89e-05	0.000962	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—TGFB1—systemic lupus erythematosus	9.85e-05	0.0023	CbGpPWpGaD
Treprostinil—Rash—Cyclosporine—systemic lupus erythematosus	9.81e-05	0.000954	CcSEcCtD
Treprostinil—Anorexia—Prednisone—systemic lupus erythematosus	9.81e-05	0.000953	CcSEcCtD
Treprostinil—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.8e-05	0.000953	CcSEcCtD
Treprostinil—Pruritus—Hydrocortisone—systemic lupus erythematosus	9.78e-05	0.000951	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	9.77e-05	0.00095	CcSEcCtD
Treprostinil—Headache—Cyclosporine—systemic lupus erythematosus	9.75e-05	0.000948	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—systemic lupus erythematosus	9.74e-05	0.000947	CcSEcCtD
Treprostinil—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	9.73e-05	0.000946	CcSEcCtD
Treprostinil—Feeling abnormal—Betamethasone—systemic lupus erythematosus	9.73e-05	0.000946	CcSEcCtD
Treprostinil—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	9.66e-05	0.000939	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	9.66e-05	0.000939	CcSEcCtD
Treprostinil—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.65e-05	0.000938	CcSEcCtD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	9.58e-05	0.00224	CbGpPWpGaD
Treprostinil—Rash—Mycophenolate mofetil—systemic lupus erythematosus	9.57e-05	0.00093	CcSEcCtD
Treprostinil—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	9.56e-05	0.00093	CcSEcCtD
Treprostinil—Headache—Mycophenolate mofetil—systemic lupus erythematosus	9.51e-05	0.000924	CcSEcCtD
Treprostinil—Malaise—Methotrexate—systemic lupus erythematosus	9.5e-05	0.000924	CcSEcCtD
Treprostinil—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	9.46e-05	0.00092	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	9.37e-05	0.000911	CcSEcCtD
Treprostinil—Dizziness—Prednisolone—systemic lupus erythematosus	9.36e-05	0.00091	CcSEcCtD
Treprostinil—Asthenia—Triamcinolone—systemic lupus erythematosus	9.34e-05	0.000908	CcSEcCtD
Treprostinil—Abdominal pain—Betamethasone—systemic lupus erythematosus	9.34e-05	0.000908	CcSEcCtD
Treprostinil—Abdominal pain—Dexamethasone—systemic lupus erythematosus	9.34e-05	0.000908	CcSEcCtD
Treprostinil—Body temperature increased—Dexamethasone—systemic lupus erythematosus	9.34e-05	0.000908	CcSEcCtD
Treprostinil—Body temperature increased—Betamethasone—systemic lupus erythematosus	9.34e-05	0.000908	CcSEcCtD
Treprostinil—Asthenia—Methylprednisolone—systemic lupus erythematosus	9.32e-05	0.000906	CcSEcCtD
Treprostinil—Insomnia—Prednisone—systemic lupus erythematosus	9.3e-05	0.000905	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	9.28e-05	0.00217	CbGpPWpGaD
Treprostinil—Nausea—Cyclosporine—systemic lupus erythematosus	9.24e-05	0.000898	CcSEcCtD
Treprostinil—Paraesthesia—Prednisone—systemic lupus erythematosus	9.24e-05	0.000898	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.24e-05	0.00216	CbGpPWpGaD
Treprostinil—Pruritus—Triamcinolone—systemic lupus erythematosus	9.21e-05	0.000896	CcSEcCtD
Treprostinil—Cough—Methotrexate—systemic lupus erythematosus	9.19e-05	0.000894	CcSEcCtD
Treprostinil—Pruritus—Methylprednisolone—systemic lupus erythematosus	9.19e-05	0.000894	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—P2RY12—systemic lupus erythematosus	9.16e-05	0.00214	CbGpPWpGaD
Treprostinil—Dizziness—Hydrocortisone—systemic lupus erythematosus	9.14e-05	0.000889	CcSEcCtD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.11e-05	0.00213	CbGpPWpGaD
Treprostinil—Dyspepsia—Prednisone—systemic lupus erythematosus	9.06e-05	0.00088	CcSEcCtD
Treprostinil—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	9.02e-05	0.000876	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.98e-05	0.0021	CbGpPWpGaD
Treprostinil—Chest pain—Methotrexate—systemic lupus erythematosus	8.97e-05	0.000872	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—systemic lupus erythematosus	8.97e-05	0.000872	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—systemic lupus erythematosus	8.97e-05	0.000872	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	8.97e-05	0.0021	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	8.96e-05	0.00209	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.95e-05	0.00209	CbGpPWpGaD
Treprostinil—Decreased appetite—Prednisone—systemic lupus erythematosus	8.94e-05	0.000869	CcSEcCtD
Treprostinil—Rash—Prednisolone—systemic lupus erythematosus	8.93e-05	0.000868	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—systemic lupus erythematosus	8.92e-05	0.000867	CcSEcCtD
Treprostinil—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	8.89e-05	0.000864	CcSEcCtD
Treprostinil—Fatigue—Prednisone—systemic lupus erythematosus	8.87e-05	0.000862	CcSEcCtD
Treprostinil—Headache—Prednisolone—systemic lupus erythematosus	8.87e-05	0.000862	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—systemic lupus erythematosus	8.86e-05	0.000862	CcSEcCtD
Treprostinil—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.79e-05	0.000855	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—C3—systemic lupus erythematosus	8.74e-05	0.00204	CbGpPWpGaD
Treprostinil—Rash—Hydrocortisone—systemic lupus erythematosus	8.72e-05	0.000848	CcSEcCtD
Treprostinil—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.71e-05	0.000847	CcSEcCtD
Treprostinil—Headache—Hydrocortisone—systemic lupus erythematosus	8.66e-05	0.000842	CcSEcCtD
Treprostinil—PPARD—Gene Expression—HIST2H2AC—systemic lupus erythematosus	8.63e-05	0.00202	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	8.63e-05	0.00202	CbGpPWpGaD
Treprostinil—Dizziness—Triamcinolone—systemic lupus erythematosus	8.61e-05	0.000837	CcSEcCtD
Treprostinil—Dizziness—Methylprednisolone—systemic lupus erythematosus	8.59e-05	0.000835	CcSEcCtD
Treprostinil—Infection—Methotrexate—systemic lupus erythematosus	8.54e-05	0.00083	CcSEcCtD
Treprostinil—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.51e-05	0.00199	CbGpPWpGaD
Treprostinil—Feeling abnormal—Prednisone—systemic lupus erythematosus	8.48e-05	0.000824	CcSEcCtD
Treprostinil—Asthenia—Dexamethasone—systemic lupus erythematosus	8.48e-05	0.000824	CcSEcCtD
Treprostinil—Asthenia—Betamethasone—systemic lupus erythematosus	8.48e-05	0.000824	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—JAK1—systemic lupus erythematosus	8.44e-05	0.00197	CbGpPWpGaD
Treprostinil—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	8.42e-05	0.000818	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	8.41e-05	0.000818	CcSEcCtD
Treprostinil—Nausea—Prednisolone—systemic lupus erythematosus	8.41e-05	0.000818	CcSEcCtD
Treprostinil—Pruritus—Betamethasone—systemic lupus erythematosus	8.36e-05	0.000813	CcSEcCtD
Treprostinil—Pruritus—Dexamethasone—systemic lupus erythematosus	8.36e-05	0.000813	CcSEcCtD
Treprostinil—Vomiting—Triamcinolone—systemic lupus erythematosus	8.28e-05	0.000805	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.27e-05	0.00193	CbGpPWpGaD
Treprostinil—Vomiting—Methylprednisolone—systemic lupus erythematosus	8.26e-05	0.000803	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.23e-05	0.00193	CbGpPWpGaD
Treprostinil—Nausea—Hydrocortisone—systemic lupus erythematosus	8.21e-05	0.000799	CcSEcCtD
Treprostinil—Rash—Triamcinolone—systemic lupus erythematosus	8.21e-05	0.000798	CcSEcCtD
Treprostinil—Dermatitis—Triamcinolone—systemic lupus erythematosus	8.2e-05	0.000797	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—systemic lupus erythematosus	8.2e-05	0.000797	CcSEcCtD
Treprostinil—Rash—Methylprednisolone—systemic lupus erythematosus	8.19e-05	0.000796	CcSEcCtD
Treprostinil—Dermatitis—Methylprednisolone—systemic lupus erythematosus	8.18e-05	0.000796	CcSEcCtD
Treprostinil—Headache—Triamcinolone—systemic lupus erythematosus	8.16e-05	0.000793	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—IL6—systemic lupus erythematosus	8.14e-05	0.0019	CbGpPWpGaD
Treprostinil—Headache—Methylprednisolone—systemic lupus erythematosus	8.14e-05	0.000791	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—systemic lupus erythematosus	8.13e-05	0.000791	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—systemic lupus erythematosus	8.13e-05	0.000791	CcSEcCtD
Treprostinil—Diarrhoea—Betamethasone—systemic lupus erythematosus	8.08e-05	0.000786	CcSEcCtD
Treprostinil—Diarrhoea—Dexamethasone—systemic lupus erythematosus	8.08e-05	0.000786	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—C3—systemic lupus erythematosus	8.05e-05	0.00188	CbGpPWpGaD
Treprostinil—Hypotension—Methotrexate—systemic lupus erythematosus	8.03e-05	0.000781	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IL2RA—systemic lupus erythematosus	7.88e-05	0.00184	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	7.83e-05	0.000762	CcSEcCtD
Treprostinil—Dizziness—Betamethasone—systemic lupus erythematosus	7.81e-05	0.00076	CcSEcCtD
Treprostinil—Dizziness—Dexamethasone—systemic lupus erythematosus	7.81e-05	0.00076	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—systemic lupus erythematosus	7.78e-05	0.000756	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—JAK1—systemic lupus erythematosus	7.77e-05	0.00182	CbGpPWpGaD
Treprostinil—Nausea—Triamcinolone—systemic lupus erythematosus	7.73e-05	0.000752	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—systemic lupus erythematosus	7.72e-05	0.000751	CcSEcCtD
Treprostinil—Nausea—Methylprednisolone—systemic lupus erythematosus	7.72e-05	0.00075	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—F2—systemic lupus erythematosus	7.68e-05	0.0018	CbGpPWpGaD
Treprostinil—Dyspnoea—Methotrexate—systemic lupus erythematosus	7.67e-05	0.000745	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	7.62e-05	0.00178	CbGpPWpGaD
Treprostinil—Dyspepsia—Methotrexate—systemic lupus erythematosus	7.57e-05	0.000736	CcSEcCtD
Treprostinil—Vomiting—Betamethasone—systemic lupus erythematosus	7.51e-05	0.00073	CcSEcCtD
Treprostinil—Vomiting—Dexamethasone—systemic lupus erythematosus	7.51e-05	0.00073	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—systemic lupus erythematosus	7.47e-05	0.000727	CcSEcCtD
Treprostinil—Rash—Betamethasone—systemic lupus erythematosus	7.45e-05	0.000724	CcSEcCtD
Treprostinil—Rash—Dexamethasone—systemic lupus erythematosus	7.45e-05	0.000724	CcSEcCtD
Treprostinil—Dermatitis—Betamethasone—systemic lupus erythematosus	7.44e-05	0.000724	CcSEcCtD
Treprostinil—Dermatitis—Dexamethasone—systemic lupus erythematosus	7.44e-05	0.000724	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—systemic lupus erythematosus	7.41e-05	0.000721	CcSEcCtD
Treprostinil—Headache—Dexamethasone—systemic lupus erythematosus	7.4e-05	0.00072	CcSEcCtD
Treprostinil—Headache—Betamethasone—systemic lupus erythematosus	7.4e-05	0.00072	CcSEcCtD
Treprostinil—Asthenia—Prednisone—systemic lupus erythematosus	7.38e-05	0.000718	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	7.38e-05	0.00173	CbGpPWpGaD
Treprostinil—Pain—Methotrexate—systemic lupus erythematosus	7.35e-05	0.000715	CcSEcCtD
Treprostinil—PPARD—Metabolism—NAT2—systemic lupus erythematosus	7.34e-05	0.00172	CbGpPWpGaD
Treprostinil—Pruritus—Prednisone—systemic lupus erythematosus	7.28e-05	0.000708	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IL2RA—systemic lupus erythematosus	7.26e-05	0.0017	CbGpPWpGaD
Treprostinil—Feeling abnormal—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000689	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—F2—systemic lupus erythematosus	7.06e-05	0.00165	CbGpPWpGaD
Treprostinil—Diarrhoea—Prednisone—systemic lupus erythematosus	7.04e-05	0.000684	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	7.03e-05	0.000684	CcSEcCtD
Treprostinil—Nausea—Betamethasone—systemic lupus erythematosus	7.02e-05	0.000682	CcSEcCtD
Treprostinil—Nausea—Dexamethasone—systemic lupus erythematosus	7.02e-05	0.000682	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	7e-05	0.00164	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	6.94e-05	0.00162	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.88e-05	0.00161	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—F2—systemic lupus erythematosus	6.86e-05	0.00161	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.84e-05	0.0016	CbGpPWpGaD
Treprostinil—Dizziness—Prednisone—systemic lupus erythematosus	6.8e-05	0.000661	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.8e-05	0.000661	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.8e-05	0.000661	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	6.79e-05	0.00159	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6.7e-05	0.00157	CbGpPWpGaD
Treprostinil—Vomiting—Prednisone—systemic lupus erythematosus	6.54e-05	0.000636	CcSEcCtD
Treprostinil—Rash—Prednisone—systemic lupus erythematosus	6.49e-05	0.000631	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—systemic lupus erythematosus	6.48e-05	0.00063	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.45e-05	0.00151	CbGpPWpGaD
Treprostinil—Headache—Prednisone—systemic lupus erythematosus	6.44e-05	0.000627	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.33e-05	0.00148	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—F2—systemic lupus erythematosus	6.32e-05	0.00148	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.3e-05	0.00147	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	6.25e-05	0.00146	CbGpPWpGaD
Treprostinil—Asthenia—Methotrexate—systemic lupus erythematosus	6.17e-05	0.0006	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6.17e-05	0.00144	CbGpPWpGaD
Treprostinil—Nausea—Prednisone—systemic lupus erythematosus	6.11e-05	0.000594	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—systemic lupus erythematosus	6.08e-05	0.000591	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—TLR9—systemic lupus erythematosus	6.07e-05	0.00142	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—JUNB—systemic lupus erythematosus	6.04e-05	0.00141	CbGpPWpGaD
Treprostinil—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.88e-05	0.000572	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.83e-05	0.00136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	5.75e-05	0.00134	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—systemic lupus erythematosus	5.7e-05	0.00133	CbGpPWpGaD
Treprostinil—Dizziness—Methotrexate—systemic lupus erythematosus	5.69e-05	0.000553	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—TLR9—systemic lupus erythematosus	5.59e-05	0.00131	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.55e-05	0.0013	CbGpPWpGaD
Treprostinil—Vomiting—Methotrexate—systemic lupus erythematosus	5.47e-05	0.000531	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—NOS3—systemic lupus erythematosus	5.45e-05	0.00128	CbGpPWpGaD
Treprostinil—Rash—Methotrexate—systemic lupus erythematosus	5.42e-05	0.000527	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—systemic lupus erythematosus	5.42e-05	0.000527	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—P2RY12—systemic lupus erythematosus	5.41e-05	0.00127	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CSK—systemic lupus erythematosus	5.41e-05	0.00127	CbGpPWpGaD
Treprostinil—Headache—Methotrexate—systemic lupus erythematosus	5.39e-05	0.000524	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—JAK1—systemic lupus erythematosus	5.34e-05	0.00125	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—RXRA—systemic lupus erythematosus	5.29e-05	0.00124	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—systemic lupus erythematosus	5.25e-05	0.00123	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.24e-05	0.00123	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.11e-05	0.0012	CbGpPWpGaD
Treprostinil—Nausea—Methotrexate—systemic lupus erythematosus	5.11e-05	0.000497	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.06e-05	0.00118	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS3—systemic lupus erythematosus	5.02e-05	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.98e-05	0.00117	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CSK—systemic lupus erythematosus	4.98e-05	0.00116	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NCF2—systemic lupus erythematosus	4.95e-05	0.00116	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—C3—systemic lupus erythematosus	4.94e-05	0.00116	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LYN—systemic lupus erythematosus	4.92e-05	0.00115	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.91e-05	0.00115	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.85e-05	0.00113	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	4.84e-05	0.00113	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.82e-05	0.00113	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—VDR—systemic lupus erythematosus	4.79e-05	0.00112	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.65e-05	0.00109	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—systemic lupus erythematosus	4.62e-05	0.00108	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.59e-05	0.00107	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.59e-05	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.59e-05	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NCF2—systemic lupus erythematosus	4.56e-05	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—C3—systemic lupus erythematosus	4.55e-05	0.00106	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LYN—systemic lupus erythematosus	4.53e-05	0.00106	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.53e-05	0.00106	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—C3—systemic lupus erythematosus	4.49e-05	0.00105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.46e-05	0.00104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.44e-05	0.00104	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—F2—systemic lupus erythematosus	4.34e-05	0.00101	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NR3C1—systemic lupus erythematosus	4.31e-05	0.00101	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—systemic lupus erythematosus	4.25e-05	0.000995	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.23e-05	0.000988	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.16e-05	0.000974	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—EP300—systemic lupus erythematosus	4.15e-05	0.00097	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—C3—systemic lupus erythematosus	4.13e-05	0.000966	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—RXRA—systemic lupus erythematosus	4.11e-05	0.000962	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—F2—systemic lupus erythematosus	3.99e-05	0.000934	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.96e-05	0.000926	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—F2—systemic lupus erythematosus	3.94e-05	0.000921	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—systemic lupus erythematosus	3.93e-05	0.000919	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUNB—systemic lupus erythematosus	3.88e-05	0.000908	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—EP300—systemic lupus erythematosus	3.82e-05	0.000893	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.82e-05	0.000892	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.69e-05	0.000863	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.64e-05	0.000852	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—F2—systemic lupus erythematosus	3.63e-05	0.000848	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—systemic lupus erythematosus	3.62e-05	0.000846	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—systemic lupus erythematosus	3.61e-05	0.000843	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRL—systemic lupus erythematosus	3.58e-05	0.000837	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUNB—systemic lupus erythematosus	3.57e-05	0.000836	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.51e-05	0.000821	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.4e-05	0.000794	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—systemic lupus erythematosus	3.34e-05	0.000781	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—systemic lupus erythematosus	3.32e-05	0.000776	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRL—systemic lupus erythematosus	3.29e-05	0.00077	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.23e-05	0.000756	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.19e-05	0.000746	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.93e-05	0.000686	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.92e-05	0.000683	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JAK1—systemic lupus erythematosus	2.86e-05	0.000669	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—systemic lupus erythematosus	2.71e-05	0.000634	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.69e-05	0.000629	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.67e-05	0.000625	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—systemic lupus erythematosus	2.65e-05	0.00062	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C3—systemic lupus erythematosus	2.65e-05	0.00062	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAK1—systemic lupus erythematosus	2.63e-05	0.000616	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—systemic lupus erythematosus	2.6e-05	0.000607	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—systemic lupus erythematosus	2.5e-05	0.000584	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.46e-05	0.000575	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—systemic lupus erythematosus	2.44e-05	0.000571	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C3—systemic lupus erythematosus	2.44e-05	0.00057	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—systemic lupus erythematosus	2.34e-05	0.000546	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2—systemic lupus erythematosus	2.33e-05	0.000544	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—systemic lupus erythematosus	2.23e-05	0.000522	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD80—systemic lupus erythematosus	2.23e-05	0.000522	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2—systemic lupus erythematosus	2.14e-05	0.000501	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—systemic lupus erythematosus	2.07e-05	0.000485	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD80—systemic lupus erythematosus	2.05e-05	0.00048	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—systemic lupus erythematosus	2.04e-05	0.000478	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—systemic lupus erythematosus	1.91e-05	0.000446	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TYK2—systemic lupus erythematosus	1.88e-05	0.00044	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.86e-05	0.000434	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—systemic lupus erythematosus	1.85e-05	0.000432	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TYK2—systemic lupus erythematosus	1.73e-05	0.000405	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—systemic lupus erythematosus	1.7e-05	0.000398	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—EP300—systemic lupus erythematosus	1.7e-05	0.000397	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.6e-05	0.000375	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—systemic lupus erythematosus	1.57e-05	0.000367	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—systemic lupus erythematosus	1.56e-05	0.000365	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—systemic lupus erythematosus	1.48e-05	0.000347	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.48e-05	0.000346	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.48e-05	0.000345	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.47e-05	0.000345	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—systemic lupus erythematosus	1.44e-05	0.000337	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—systemic lupus erythematosus	1.44e-05	0.000336	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EP300—systemic lupus erythematosus	1.41e-05	0.000329	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.36e-05	0.000319	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.36e-05	0.000318	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.33e-05	0.000311	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EP300—systemic lupus erythematosus	1.29e-05	0.000303	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.23e-05	0.000287	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.22e-05	0.000286	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.17e-05	0.000274	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.12e-05	0.000263	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.05e-05	0.000247	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.22e-06	0.000216	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—systemic lupus erythematosus	9.21e-06	0.000215	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—systemic lupus erythematosus	8.48e-06	0.000198	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.27e-06	0.000193	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.67e-06	0.000179	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.22e-06	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	4.7e-06	0.00011	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.49e-06	0.000105	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.11e-06	9.61e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.42e-06	7.99e-05	CbGpPWpGaD
